Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 2008 Feb 12;105(7):2628–2633. doi: 10.1073/pnas.0711642105

Wound angiogenesis as a function of tissue oxygen tension: A mathematical model

Richard C Schugart †, Avner Friedman †,‡,§, Rui Zhao , Chandan K Sen †,‡
PMCID: PMC2268187  PMID: 18272493

Abstract

Wound healing represents a well orchestrated reparative response that is induced by injuries. Angiogenesis plays a central role in wound healing. In this work, we sought to develop the first mathematical model directed at addressing the role of tissue oxygen tension on cutaneous wound healing. Key components of the developed model include capillary tips, capillary sprouts, fibroblasts, inflammatory cells, chemoattractants, oxygen, and the extracellular matrix. The model consists of a system of nonlinear partial differential equations describing the interactions in space and time of these variables. The simulated results agree with the reported literature on the biology of wound healing. The proposed model represents a useful tool to analyze strategies for improved healing and generate a hypothesis for experimental testing.

Keywords: therapeutics, redox, translational research, hypoxia, hyperoxia


Injury incites the most rapid and definable neovascularization (1). Healing wounds make excellent experimental models that can provide otherwise unavailable insights into the nature of angiogenesis (2). However, a series of events must occur for a vascular network to form in the wound site. The process begins with bleeding, when angiogenic blood products are spilled into the injured site. Platelets and proteins come into the wound to form a clot. Inflammatory cells, like neutrophils and macrophages, migrate into the wound to degrade necrotic tissue and bacteria. The coagulation proteins, inflammatory cells, and metabolic by-products provide a flood of growth and angiogenic factors into the wound environment, which is conditioned to a moderate hypoxia, an accumulation of lactate, a slight lowering of pH, and an elevation of pCO2 (3, 4). These angiogenic factors recruit fibroblasts and endothelial cells, which accumulate in the wound region. The accumulation of cells increases the requirement for a blood supply, usually well beyond the capacity of the normal vessels that once fed the site. The fibroblasts respond to the metabolic need of new vessels by laying the extracellular matrix in which the capillary tubes form, whereas the endothelial cells line the capillary tubes that allow for blood flow into the repaired wound site. Once the metabolic needs of healing are met and the wound closes, the new vessels regress, leaving a vascularized fibrous scar containing a collagenous matrix that persists somewhat in proportion to the degree to which inflammation has occurred and the time that has been required for healing. In short, wound angiogenesis represents a response to coagulation, inflammation, and temporary metabolic need (3, 4).

Disruption of the vasculature at the wound site is responsible for wound-site hypoxia (5, 6). Although hypoxia is generally recognized as a physiological cue to induce angiogenesis (7–10), severe hypoxia cannot sustain the growth of functional blood vessels (2, 11–14). Interestingly, like hypoxia, hyperoxia also induces the expression of angiogenic factors and supports wound angiogenesis and healing (2, 15–17). Oxygen therapy is commonly used in the wound clinics to treat wound hypoxia (20–24). Extreme hyperoxia, on the other hand, can cause oxygen toxicity and derail tissue repair (16, 17, 19).

One of the first mathematical models on dermal wound angiogenesis was a three-variable system of partial differential equations that describes the evolution of the capillary-tip endothelial cells, macrophage-derived chemoattractants, and the new blood vessels during the tissue repair process (25). This model was later expanded to incorporate the roles of fibroblasts, oxygen, and extracellular matrix in the wound-healing process (26). More recently, a three-variable model, similar to that in ref. (25), was shown to be in agreement with clinical data on wound surface area for both normal and chronic wounds (27). Later on, mathematical models of angiogenic networks, such as through the induction of vascular networks by vascular endothelial growth factors (VEGFs) (28, 29), were developed by McDougall and coworkers (30, 31), based in part on the work of Anderson and Chaplain (32), in connection with chemotherapeutic strategies. In this work, our objective was to develop a mathematical model directed at addressing excisional cutaneous wound angiogenesis as a function of tissue oxygen tension. The present work builds on the mathematical model developed in ref. (26) by also incorporating the effects of macrophages and the use of oxygen treatment for the wound.

Results and Discussion

A system of nonlinear partial differential equations describing the interactions in space and time of select biological factors that are known to regulate wound angiogenesis was used to develop the proposed model. The process of wound healing involves complex interactions among a number of factors. In the early inflammation phase, the blood-borne inflammatory cells migrate into the wound site releasing a variety of angiogenic growth factors, such as VEGF. These factors interact chemotactically with resident cells such as fibroblasts. The fibroblasts produce collagen and other components of the ECM. Successful laying of the ECM facilitates the migration of fibroblasts, smooth muscle cells, marrow-derived cells, and endothelial cells into the wound. Endothelial cells proliferate and align on the three-dimensional matrix to form a network of capillaries. As soon as the anastomoses start to occur, blood begins to flow through the capillaries. In this study, for mathematical simplicity, the angiogenic response was estimated by the density of endothelial cells lining the capillary walls and was referred to as the capillary sprouts. Finally, oxygen is centrally essential for wound disinfection and to support the metabolism and signaling underlying wound repair (5, 33).

The proposed mathematical model is based on the following variables: n, density of capillary tips; b, density of capillary sprouts; w, concentration of oxygen; m, density of inflammatory cells (e.g., macrophages and neutrophils); a, concentration of chemoattractants (e.g., VEGF and other growth factors); f, density of fibroblasts; and ρ, density of ECM.

The primary aim of developing the proposed model was to produce simulation results that qualitatively agree with experimental findings reported in the current literature. Where applicable, parameters were obtained from experimental data reported in the literature. Other parameters were estimated based on related observations in the literature. The proposed model also includes a control term corresponding to therapeutic oxygen supplementation regimens. Hence, the model developed herein can be used to generate hypotheses on optimal treatment of wounds by varying the oxygen therapy regimen for wound care. Assumptions related to the variables considered for developing the proposed mathematical model are described below.

Capillary Tips.

It was assumed that the flux of the capillary tips is given by Jn = −(Dn∇n − χn(n,ρ)∇a) where Dn is a diffusion coefficient and χn(n,ρ) = χn (ρ/ρ0) nH(n0 − n) is a chemotactic term. H(n) is the Heaviside function, where H(n) = 1 for n ≥ 0 and H(n) = 0, otherwise. The Heaviside function is introduced here to ensure that n does not exceed n0. Note that there is no chemotactic response in the absence of extracellular matrix (34, 35). The new capillary tips are assumed to be produced from the tips themselves, as well as from sprouts, and that capillary tip production depends on the presence of the chemoattractant. Loss terms caused by sprout–tip and tip–tip anastomoses are also included (36, 37). From these assumptions, the equation for the capillary tips is:

graphic file with name zpq00708-9126-m01.jpg

Capillary Sprouts.

It was assumed that the capillary sprouts undergo diffusion, and, at the same time, are dragged along the flux of the tips (38–40). The velocity of the tips is vn = (1/n) Jn, so that the sprouts move in the same direction as the tips with velocity vb = gb(n) vn. Note that gb(n) depends on n because the drag velocity will be very small if n is small; it is assumed that gb(n) = An/n0. A logistic term is also included, where it is assumed that the maximum capillary sprout density depends on the tissue oxygen tension Gb(w/w0) and Gb(1) = 1. Because the material derivative of b is given by ∂b/∂t + ∇· (bvb), the equation for the capillary sprouts is:

graphic file with name zpq00708-9126-m02.jpg

Oxygen.

It was assumed that the oxygen undergoes diffusion through the capillary vasculature (41, 42), and oxygen is lost through consumption by fibroblasts and macrophages (43, 44). An intervention term G(w/w0) that represents the input of oxygen by using therapeutic approaches was also included. Thus, the equation for the concentration of oxygen is:

graphic file with name zpq00708-9126-m03.jpg

An appropriate choice of G(w/w0) to examine how the healing process can be improved is discussed later in this article.

Inflammatory Cells.

Inflammatory cells (i.e., macrophages and neutrophils) assist in wound healing by migrating to the injury site where they release angiogenic growth factors that promote the ingrowth of new blood vessels to the wound space. It was assumed that the flux of macrophages is given by Jm = − (Dm∇m + χm(m)∇w), where χm(m) = χmmH(m0 − m) is a chemotactic term. As in the case of the capillary tips, 0 ≤ m ≤ m0 is expected. It was also assumed that macrophages decay or lose functionality at a linear rate. Hence, the equation for inflammatory cells is:

graphic file with name zpq00708-9126-m04.jpg

Chemoattractant.

Many different families of inflammatory growth factors are known to regulate fibroblasts and endothelial cells. In this work, a single, generic growth factor whose properties simulate the combined effect of in vivo promoters of healing, such as VEGF, was considered. It was assumed that the concentration of chemoattractant undergoes random motion, and that it decreases through decay and through uptake by tips and sprouts. Finally, the concentration rate was assumed to increase in proportion to both the concentration of macrophages and the density of oxygen Ga(w/w0), where Ga(1) = 1. Hence, the equation for the chemoattractant is:

graphic file with name zpq00708-9126-m05.jpg

Fibroblasts.

It was assumed that the flux of fibroblasts is given by Jf = − (Df∇f − χf(f)∇a), where χf(f) = χfH(f0 − f). A logistic term, which depends on the tissue oxygen concentration Gf(w/w0), was also included, where Gf(1) = 1. With the inclusion of a death term, the equation for the fibroblasts is:

graphic file with name zpq00708-9126-m06.jpg

ECM.

It was assumed that the buildup of ECM depends on fibroblast function (45, 46) in the same manner that capillary sprout motion depends on the motion of the capillary tips; that is, the velocity vρ of the ECM density is given by vρ = (gρ(f)f) Jf, where gρ(f) = B (f/f0) is prescribed. A term that drives the ECM to its repaired value ρ0 and a diffusion term with a small coefficient Dρ are also included. Because the material derivative of ρ is given by ∂ρ/∂t + ∇ · (ρvρ), the equation for the extracellular matrix is:

graphic file with name zpq00708-9126-m07.jpg

Boundary and Initial Conditions.

For simplicity, a radial cross-section of the wound was taken as an interval 0 ≤ x ≤ L, where L is the radius of the wound, and the partial differential equation system Eqs. 1–7 is solved in this interval. The endpoint x = L corresponds to the edge of the healthy tissue, whereas x = 0 represents the center of the radial wound. Along the wound edge, it was assumed that the densities of capillary sprouts, fibroblasts, and ECM remain constant at the level of the unwounded state, and the concentration of oxygen depends on G(w/w0), which represents the concentration of oxygen in the blood in the case of systemic oxygen therapy (e.g., hyperbaric oxygen). The densities of the capillary tips and inflammatory cells are assumed to decrease at the boundary of the healthy tissue as the healing process progresses, and the flux of the chemoattractant across this boundary is negligible. Hence, the boundary conditions at x = L are:

graphic file with name zpq00708-9126-m08.jpg

At x = 0, the following no-flux boundary conditions are used:

graphic file with name zpq00708-9126-m09.jpg

To complete the system, a set of initial conditions is needed at t = 0, the time when the inflammatory cells begin to infiltrate into the wound space. The initial conditions are taken to be:

graphic file with name zpq00708-9126-m10.jpg

These initial conditions agree with boundary conditions 8 and 9 at x = 0 and x = L, and ε is selected such that all the densities are initially near zero away from the wound edge.

Table 1 lists the numerical values of the parameters for the PDE system (Eqs. 1–7) and the boundary and initial conditions 8–10. Where applicable, parameters are taken from the cited literature and are based on firm experimental data. Whenever such data were not available, the order of magnitude of the parameters was estimated and choices were made that gave the best experimentally expected results regarding angiogenesis outcome. The parameters were then tuned to make sure that they are robust, namely, that the simulation results are essentially unaffected if the changed parameters are within the same order of magnitude.

Table 1.

Table of parameters for differential equations and boundary conditions

Parameter Dimensional value Dimensionless value Source
L 0.15 cm 1 tw
n0 1 × 10−4 g·cm−3 1 (47, 48), tw
b0 1 × 10−3 g·cm−3 1 (47, 48), tw
w0 5.4 × 10−6 g·cm−3 1 (51), tw
m0 1 × 10−3 g·cm−3 1 (49), tw
a0 10−8 g·cm−3 1 (49), tw
f0 10−3 g·cm−3 1 (50), tw
ρ0 10−3 g·cm−3 1 (47)
Dn 1 × 10−9 cm2 · s−1 1 × 10−3 (25, 52)
Db 6.9 × 10−11–7.1 × 10−9 cm2·s−1 7 × 10−4 (58, 59)
Dw 5 × 10−7 cm2·s−1 0.5 (60)
Dm 5 × 10−2 tw
Da 3.1 × 10−7–5.9 × 10−6 cm2·s−1 1 (25, 59)
Df 1.7 × 10−10 cm2·s−1 1.7 × 10−4 (50)
Dρ 1 × 10−5 tw
χn 1–100 cm5 g−1·s−1 1 (25, 61)
χm (= χf) 0.1 tw
χf 10–500 cm5 g−1·s−1 0.1 (50)
A 1 tw
B 1 tw
λ1 (= 10λ2) 2.16 × 10−1 tw
λ2 2.16 × 10−2 (52), tw
λ3 1 × 10−3 cm3·g−1·s−1 2.25 × 10−2 (52)
λ4 1 × 10−1 cm3·g−1·s−1 2.25 × 10−1 (52)
λ5 5.56 × 10−6–1.56 × 10−5 s−1 2.25 × 10−1 (58, 61, 62)
λ6 (= λ7/2) 0.1388 tw
λ7 (= λ8/15) 0.277 (51), tw
λ8 0.185 cm3·g−1·s−1 4.16 (51), tw
λ9 2 × 10−6 s−1 0.045 (53), tw
λ10 50 tw
λ11 (= λ12) 4 cm3·g−1·s−1 9 tw
λ12 4 cm3·g−1·s−1 90 (63, 64)
λ13 4 × 10−5 s−1 0.9 (54, 55)
λ14 0.25 tw
λ15 2.31 × 10−7 s−1 5.2 × 10−3 (65)
λ16 0.25 tw
γ1 3 × 10−6 s−1 0.067 tw
γ2 4.4 × 10−6 s−1 0.1 tw
ε 0.001 0.001 tw

tw stands for “this work” and represents parameters estimated from this study. When a reference is given in parentheses with tw, these parameters have been estimated from information given in the corresponding citation.

Table 1 lists the parameters in both dimensional [centimeter-gram-second (cgs) units] and dimensionless form. It is the latter values that are used in the simulations. The conversion from the dimensional to dimensionless units was done as follows:

graphic file with name zpq00708-9126-m11.jpg

With the above substitutions, the nondimensionalized Eqs. 1–7 and boundary and initial conditions 8–10 become (with removal of the * for notational simplicity):

graphic file with name zpq00708-9126-m12.jpg

where H(·) is the Heaviside function, G(·) is the input of hyperbaric oxygen, and

graphic file with name zpq00708-9126-m13.jpg

Scaling Coefficients (n0, b0, w0, m0, a0, f0, ρ0).

Estimates for the number of endothelial cells ranges from 1 × 102 cells per mm3 (47) to 2 × 103 cells per mm2 in a monolayer (48); which corresponds to 1 × 105 cells per mm3. If a cube of size 1 mm3 was saturated with endothelial cells with volume 10 μm × 10 μm × 1 μm, there would be 107 cells. Because the cells weigh the same as water, the endothelial cells in 1 cm3 weigh between 10−5 and 10−2 g. Hence, b0 = 1 × 10−3 g·cm−3 and correspondingly n0 = 1 × 10−4 g·cm−3 were taken. Similarly, the average values of m0 = f0 = 1 × 10−3 g·cm−3 were chosen, because macrophages are 10 μm × 10 μm × 10 μm and about 65 cells can occupy a volume of 0.07 mm3 for a 1-cm-thick wound (49), fibroblasts are 100 μm × 100 μm × 10 μm and about 104 cells are found in 1 cm3 of the dermis (50). Finally, w0 = 168 μM × 32 g·mol−1, where 168 μM represents the mouse reference oxygen concentration, which is taken to be 80% of the human concentration (51), and 32 g·mol−1 is the molecular mass of oxygen, O2.

Reaction Coefficients (λis).

The parameter λ2 was expected to be of the same order of magnitude as reported (52), although the precise value was not known. λ2 was chosen to be smaller than reported (52). λ1 was expected to be larger than λ2, and in the absence of experimental results, λ1 = 10 λ2 was chosen. The order of magnitude of the parameter λ8 was estimated by solving the equation dw̄dt = λ8m0w0 for λ8, where dw̄dt = k × 32 g/mol, k is the oxygen consumption rate of macrophages in a cubic centimeter, and 32 g/mol is the molecular mass of O2. The oxygen consumption rate (OCR) for macrophages is 1.87 nmol·min−1·(106 cells)−1 (51) and estimating that 106 cells occupy a volume of 1 cm3, k = 1.87 nmol·min−1·cm−3. Because the OCR of endothelial cells is about one-fifteenth of the rate for macrophages (51) and the OCR of fibroblasts is similar to that of endothelial cells, λ8* = λ7*/15. The wound being inherently hypoxic, λ6* < λ7* under the assumptions that b ∼ 1, f ∼ 1, and m ∼ 0 for t large. Hence, λ6* = λ7*/2 was chosen. The parameter λ9, the half-life of macrophages in a mouse, was estimated to be one third of that for macrophages in HIV studies (53). Uptake of the chemoattractant by endothelial cell tips was assumed to be similar to the uptake by the capillary sprouts, so λ11 = λ12. By using estimates for the VEGF-C half-life to be between 3.5 and 8 h (54, 55), λ13 = 4 × 10−5 s−1. In the absence of parameter estimates from the literature, λ10*, λ14*, and λ16* were chosen such that the healing of the mouse wound should be completed in ∼10 days (1).

The Functions (Gis).

It was assumed that Gb (w/w0) = 2w/w0 − 1 for w/w0 ≥ 1/2, 0 for 0 ≤ w/w0 < 1/2, and that Gf (w/w0) = Gb (w/w0). Ga (w/w0) will depend on the oxygen input during healing. Because a slight deviation from normoxia to hypoxia and increased hyperoxia both induce growth factors such as VEGF (2, 16, 56, 57);

graphic file with name zpq00708-9126-m14.jpg

where the internal minimum corresponds to normoxia.

Boundary Coefficients (γiS).

It was assumed that the capillary tips along the fixed boundary are at ≈10% of the original concentration after about 9 days, and that macrophages along the fixed boundary are at ≈10% of the original concentration after 6 days. Hence, γ1 = (ln 10)/9 day−1 and γ2 = (ln 10)/6 day−1.

For the simulation in Fig. 1, time profiles of the average density of endothelial cells in the entire wound, normalized to their density in the nonwounded state, are shown for different levels of tissue oxygen tension as therapeutically managed for 10 days. The oxygen concentrations are normalized such that concentration = 1 represents a normoxic environment, <1 is considered a hypoxic setting, and >1 characterizes a hyperoxic scenario. The endothelial cell density increased as the tissue oxygen concentration changed from 0.25 in the hypoxic state to 2 in the hyperoxic state. The endothelial cell density decreased as the tissue oxygen tension increased from 2 (moderately hyperoxic) to 4 (extremely hyperoxic). Furthermore, cases of extreme hypoxia (when the external oxygen concentration ranges from 0.25 to 0.5) could barely recover half of the endothelial cell density that is found in the unwounded state.

Fig. 1.

Fig. 1.

Endothelial cell density for different external oxygen concentrations. Oxygen concentrations <1 are hypoxic, and oxygen concentrations >1 are hyperoxic. The figure shows that the average endothelial cell density increases with the oxygen level from the hypoxic concentrations to hyperoxic concentrations, as long as the hyperoxic level is <2.

Fig. 2 illustrates the difference between endothelial cell densities contrasting the normoxic case of one to administering oxygen therapy for 90 min per day for 10 days for different hyperoxic concentrations by using an oxygen-supplementing device such as a hyperbaric oxygen chamber. A positive endothelial cell density difference would indicate that oxygen treatment generated an improved outcome compared with conditions of no oxygen therapy to the inherently ischemic wound. A negative difference would imply the adverse effect of oxygen treatment. For the most part, by increasing the normalized oxygen treatment levels to 2, 3, and 4, an increasingly higher density of endothelial cells was achieved. Simulations (Fig. 3) in the case when the base level represented the hyperoxic concentration of 2 showed no improvement in endothelial cell density when the oxygen level is increased to 3 or 4 for 90 min per day. This agrees with the result that high levels of oxygen are known to cause growth arrest and senescence of cells (19, 65). Fig. 4 suggests that, for the most part, using intermittent oxygen treatment for 90 min twice per day is slightly better than 90 min one time per day.

Fig. 2.

Fig. 2.

Endothelial cell density difference between constant level 1 and oscillations of base 1 with varying heights. Starting with a normoxic base level (i.e., G (w/w0) = 1), the oxygen level is increased to a level of 2, 3, and 4 for 90 min per day. The figure shows the difference between increasing the oxygen level for 90 min per day and that of a constant normoxic level of oxygen, with a positive difference indicating that treatment improves the healing process. In all cases considered, there is a positive difference (except early in the treatment process) and thus an increasing gain in endothelial cell density.

Fig. 3.

Fig. 3.

Endothelial cell density difference between constant level 2 and oscillations of base 2 with varying heights. Starting with a hyperoxic base level (i.e., G (w/w0) = 2), the oxygen level is increased to levels of 3 and 4 for 90 min per day. The figure shows the difference between increasing the oxygen level for 90 min per day and that of a constant oxygen level of 2, with a positive difference indicating that treatment improves the healing process. Increasing to a level of 3 showed no increase in the density of endothelial cells, but increasing to a level of 4 decreased the endothelial cell density.

Fig. 4.

Fig. 4.

Endothelial cell density difference between the use of intermittent oxygen treatment 90 min once per day and 90 min twice per day for increased levels 2, 3, and 4 from the normoxic level 1. A positive difference indicates that treatment twice a day is better, and a negative difference indicates treatment once per day is better. In all cases, the difference is more positive than negative, suggesting that intermittent oxygen treatment twice a day is better.

These results predicted by the developed model agree with the experimental literature on wound healing. First, the model suggests that an extremely hypoxic wound environment cannot sustain vascular growth (10–12, 14). Second, hyperoxia promotes wound angiogenesis and healing (2, 16, 18, 57). Furthermore, the model simulations indicate that there is an optimal level of hyperoxia beyond which the beneficial effects of hyperoxia may be reversed. Third, the use of intermittent oxygen treatment may stimulate angiogenic response (66).

It should be noted that the mathematical model is clearly a simplification of the complex process of wound healing. For example, it lumps all the growth factors into one species, introduces functions Gi(w) whose precise form is unknown, and describes the formation of new blood vessels in terms of endothelial cell densities. Nonetheless, the proposed mathematical model represents a starting point in the modeling of one aspect of wound angiogenesis, that is, the effect of tissue oxygen tension. Our effort was directed at focusing on multiple well established biological factors that are known to regulate wound angiogenesis. The list of factors considered herein clearly has room for expansion as the biological complexities continue to be experimentally unveiled. This work provides a mathematical model that enables simulations of how wound tissue oxygen tension may influence angiogenic outcomes. The simulated results agree with a variety of experimental findings. As such, the model represents a useful tool to analyze strategies for improved healing and generate hypotheses for biological testing. In addition, the current model lends itself to refinement to the next level of sophistication addressing additional factors implicated in the systems biology of wound healing.

Methods

In the process of wound healing a very large number of proteins and smaller molecules are involved. For example, there may be as many as 105 cells in 1 mm3. To simulate the complex interactions among these molecules, a standard approximation was used, whereby individual cells were replaced by their density. The density of endothelial cells at location x is defined as the number of cells in a small volume containing x divided by this volume, as this volume becomes “arbitrarily” small. The densities of fibroblasts, VEGF, etc., are similarly defined. These densities depend on space and time, and they undergo continuous changes as a result of their mutual complex interactions. These changes are expressed by a system of nonlinear partial differential equations.

The wound occupies a three-dimensional space, but to simplify the computations, only its two-dimensional projection was considered. It was further assumed that this projection is circular, so that the boundary of the wound is a circle and all the densities depend only on time and on the distance from the center of the wound. The problem was solved on a radial cross-section of the circular wound. The system of partial differential equations was solved by using the Matlab command pdepe, which uses the method in ref. 68 for the spatial discretization and the Matlab routine of ode15s for the time integration. At each time, t, the profile of the endothelial cell density was computed and then averaged over the wound area. These averages were displayed in Fig. 1 for different choices of the oxygen intervention term G(w/w0).

ACKNOWLEDGMENTS.

This work was supported by National Science Foundation Award 0112050 and National Institutes of Health Grants RO1 HL 073087, GM 077185, and GM 069589.

Footnotes

The authors declare no conflict of interest.

References

  • 1.Roy S, et al. Dermal wound healing ins subject to redox control. Mol Ther. 2006;13:211–220. doi: 10.1016/j.ymthe.2005.07.684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Hopf HW, et al. Hyperoxia and angiogenesis. Wound Repair Regen. 2005;13:558–564. doi: 10.1111/j.1524-475X.2005.00078.x. [DOI] [PubMed] [Google Scholar]
  • 3.Hunt TK, Hopf H, Hussain Z. Physiology of wound healing. Adv Skin Wound Care. 2000;13:6–11. [PubMed] [Google Scholar]
  • 4.Suh DY, Hunt TK. Time line of wound healing. Clin Podiatr Med Surg. 1998;15:1–9. [PubMed] [Google Scholar]
  • 5.Gordillo GM, Sen CK. Revisiting the essential role of oxygen in wound healing. Am J Surg. 2003;186:259–263. doi: 10.1016/s0002-9610(03)00211-3. [DOI] [PubMed] [Google Scholar]
  • 6.Hunt T, Twomey P, Zederfeldt B, Dunphy J. Respiratory gas tensions and pH in healing wounds. Am J Surg. 1967;114:302–307. doi: 10.1016/0002-9610(67)90388-1. [DOI] [PubMed] [Google Scholar]
  • 7.Colgan SM, Mukherjee S, Major P. Hypoxia-induced lactate dehydrogenase expression and tumor angiogenesis. Clin Colorectal Cancer. 2007;6:442–446. doi: 10.3816/CCC.2007.n.014. [DOI] [PubMed] [Google Scholar]
  • 8.Semenza GL. HIF-1: Using two hands to flip the angiogenic coin. Cancer Metastasis Rev. 2000;19:59–65. doi: 10.1023/a:1026544214667. [DOI] [PubMed] [Google Scholar]
  • 9.Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: Role of the HIF system. Nat Med. 2003;9:677–684. doi: 10.1038/nm0603-677. [DOI] [PubMed] [Google Scholar]
  • 10.Liao D, Johnson RS. Hypoxia: A key regulator of angiogenesis in cancer. Cancer Metastasis Rev. 2007;26:281–290. doi: 10.1007/s10555-007-9066-y. [DOI] [PubMed] [Google Scholar]
  • 11.Allen DB, et al. Wound hypoxia nad acidosis limit neutrophil bacterial killing mechanisms. Arch Surg. 1997;132:991–996. doi: 10.1001/archsurg.1997.01430330057009. [DOI] [PubMed] [Google Scholar]
  • 12.Gibson JJ, Angeles AP, Hunt TK. Increased oxygen tension potentiates angiogenesis. Surg Forum. 1997;48:696–699. [Google Scholar]
  • 13.Oberringer M, Jennewein M, Motsch SE, Pohlemann T, Seekamp A. Different cell cycle responses of wound healing protagonists to transient in vitro hypoxia. Histochem Cell Biol. 2005;125:595–603. doi: 10.1007/s00418-005-0782-5. [DOI] [PubMed] [Google Scholar]
  • 14.Safran M, Kaelin WGJ. HIF hydroxylation and the mammalian oxygen-sensing pathway. J Clin Invest. 2003;111:779–783. doi: 10.1172/JCI18181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Fries RB, et al. Dermal excisional wound healing in pigs following treatment with topically applied pure oxygen. Mutat Res. 2005;579:172–181. doi: 10.1016/j.mrfmmm.2005.02.023. [DOI] [PubMed] [Google Scholar]
  • 16.Patel V, et al. Oxygen: From the benefits of inducing VEGF expression to managing the risk of hyperbaric stress. Antioxid Redox Signal. 2005;7:1377–1387. doi: 10.1089/ars.2005.7.1377. [DOI] [PubMed] [Google Scholar]
  • 17.Raa A, et al. Hyperoxia retards growth and induces apoptosis and loss of glands and blood vessels in DMBA-induced rat mammary glands. BMC Cancer. 2007;7:23. doi: 10.1186/1471-2407-7-23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Sheikh AY, Rollins MD, Hopf HW, Hunt TK. Hyperoxia improves microvascular perfusion in a murine wound model. Wound Repair Regen. 2005;13:303–308. doi: 10.1111/j.1067-1927.2005.130313.x. [DOI] [PubMed] [Google Scholar]
  • 19.Uno K, Merges CA, Grebe R, Lutty GA, Prow TW. Hyperoxia inhibits several critical aspects of vascular development. Dev Dyn. 2007;236:981–990. doi: 10.1002/dvdy.21122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Al-Waili NS, Butler GJ. Effects of hyperbaric oxygen on inflammatory response to wound and trauma: possible mechanism of action. Sci World J. 2006;6:425–441. doi: 10.1100/tsw.2006.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Gallagher KA, Goldstein LJ, Thom SR, Velazquez OC. Hyperbaric oxygen and bone marrow-derived endothelial progenitor cells in dabetic wound healing. Vascular. 2006;14:328–337. doi: 10.2310/6670.2006.00057. [DOI] [PubMed] [Google Scholar]
  • 22.Mills C, Bryson P. The role of hyperbaric oxygen therapy in the treatment of sternal wound infection. Eur J Cardiothorac Surg. 2006;30:153–159. doi: 10.1016/j.ejcts.2006.03.059. [DOI] [PubMed] [Google Scholar]
  • 23.Roeckl-Wiedmann J, Bennett M, Kranke P. Systematic review of hyperbaric oxygen in the management of chronic wounds. Br J Surg. 2005;92:24–32. doi: 10.1002/bjs.4863. [DOI] [PubMed] [Google Scholar]
  • 24.Kalliainen LK, Gordillo GM, Schlanger R, Sen CK. Topical oxygen as an adjunct to wound healing: A clinical case series. Pathophysiology. 2003;9:81–87. doi: 10.1016/s0928-4680(02)00079-2. [DOI] [PubMed] [Google Scholar]
  • 25.Pettet GJ, Byrne HM, McElwain DL, Norbury J. A model of wound-healng angiogenesis in soft tissue. Math Biosci. 1996;136:35–63. doi: 10.1016/0025-5564(96)00044-2. [DOI] [PubMed] [Google Scholar]
  • 26.Pettet GJ, Chaplain MA, McElwain DL, Byrne HM. On the role of angiogenesis in wound healing. Proc R Soc London Ser B. 1996;263:1487–1493. doi: 10.1098/rspb.1996.0217. [DOI] [PubMed] [Google Scholar]
  • 27.Byrne HM, Chaplain MA, Evans DL, Hopkinson J. Mathematical modeling of angiogenesis in wound healing. J Theor Med. 2000;2:175–197. [Google Scholar]
  • 28.Dor Y, Djonov V, Keshet E. Making vascular networks in the adult: Branching morphogenesis without a roadmap. Trends Cell Biol. 2003;13:131–136. doi: 10.1016/s0962-8924(03)00022-9. [DOI] [PubMed] [Google Scholar]
  • 29.Dor Y, Djovov V, Keshet E. Induction of vascular networks in adult organs: Implications to proangiogenic therapy. Ann N Y Acad Sci. 2003;995:208–216. doi: 10.1111/j.1749-6632.2003.tb03224.x. [DOI] [PubMed] [Google Scholar]
  • 30.McDougall SR, Anderson AR, Chaplain MA, Sherratt JA. Mathematical modeling of flow through vascular networks: Implications for tumour-induced angiogenesis. B Math Biol. 2002;64:673–702. doi: 10.1006/bulm.2002.0293. [DOI] [PubMed] [Google Scholar]
  • 31.Stephanou A, McDougall SR, Anderson AR, Chaplain MA. Mathematical modelling of flow in 2D and 3D vascular networks: Applications to anti-angiogenic and chemotherapeutic drug strategies. Math Comput Model. 2005;41:1137–1156. [Google Scholar]
  • 32.Anderson AR, Chaplain MA. Continuous and discrete mathematical models of tumour-induced angiogenesis. Bull Math Biol. 1998;60:857–899. doi: 10.1006/bulm.1998.0042. [DOI] [PubMed] [Google Scholar]
  • 33.Sen CK. The general case for redox control of wound repair. Wound Repair Regen. 2003;11:431–438. doi: 10.1046/j.1524-475x.2003.11607.x. [DOI] [PubMed] [Google Scholar]
  • 34.Brown EJ. The role of extracellular matrix proteins in the control of phagocytosis. J Leukoc Biol. 1986;39:579–591. doi: 10.1002/jlb.39.5.579. [DOI] [PubMed] [Google Scholar]
  • 35.Kearns DB, Bonner PJ, Smith DR, Shimkets LJ. An extracellular matrix-associated zinc metalloprotease is required for dilauroyl phosphatidylethanolamine chemotactic excitation in Myxococcus xanthus. J Bacteriol. 2002;184:1678–1684. doi: 10.1128/JB.184.6.1678-1684.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Balding D, McElwain DL. A mathematical model of tumour-induced capillary growth. J Theor Biol. 1985;114:53–73. doi: 10.1016/s0022-5193(85)80255-1. [DOI] [PubMed] [Google Scholar]
  • 37.Edelstein L. The propagation of fungal colonies: A model for tissue growth. J Theor Biol. 1982;98:679–701. [Google Scholar]
  • 38.Chaplain MA. Mathematical modeling of angiongenesis. J Neurooncol. 2000;50:37–51. doi: 10.1023/a:1006446020377. [DOI] [PubMed] [Google Scholar]
  • 39.Jabbarzadeh E, Abrams CF. Strategies to enhance capillary formation inside biomaterials: A computational study. Tissue Eng. 2007;13:2073–2086. doi: 10.1089/ten.2006.0057. [DOI] [PubMed] [Google Scholar]
  • 40.Kettunen P, et al. Emergent reaction-diffusion phenomena in capillary tubes. Chaos. 2006;16:037111. doi: 10.1063/1.2191621. [DOI] [PubMed] [Google Scholar]
  • 41.Boag JW. Oxygen diffusion in tumour capillary networks. Bibl Anat. 1977;15:266–269. [PubMed] [Google Scholar]
  • 42.Huang P, et al. Modeling of oxygen diffusion and metabolism from capillary to muscle. Adv Exp Med Biol. 2003;540:325–330. doi: 10.1007/978-1-4757-6125-2_46. [DOI] [PubMed] [Google Scholar]
  • 43.Hutter E, Renner K, Jansen-Durr P, Gnaiger E. Biphasic oxygen kinetics of cellular respiration and linear oxygen dependence of antimycin A inhibited oxygen consumption. Mol Biol Rep. 2002;29:83–87. doi: 10.1023/a:1020322922732. [DOI] [PubMed] [Google Scholar]
  • 44.Nalwaya N, Deen WM. Nitric oxide, oxygen, and superoxide formation and consumption in macrophage cultures. Chem Res Toxicol. 2005;18:486–493. doi: 10.1021/tx049879c. [DOI] [PubMed] [Google Scholar]
  • 45.Horobin AJ, Shakesheff KM, Pritchard DI. Promotion of human dermal fibroblast migration, matrix remodelling and modification of fibroblast morphology within a novel 3D model by Lucilia sericata lavravl secretions. J Invest Dermatol. 2006;126:1410–1418. doi: 10.1038/sj.jid.5700256. [DOI] [PubMed] [Google Scholar]
  • 46.Olaso E, et al. Discoidin domain receptor 2 regulates fibroblasts proliferation and migration through the extraceullular matrix in association with transcriptional activation of matrix metalloproteinase-2. J Biol Chem. 2002;277:3606–3613. doi: 10.1074/jbc.M107571200. [DOI] [PubMed] [Google Scholar]
  • 47.Namy P, Ohayon J, Tracqui P. Critical conditions for pattern formation and in vitro tubulogenesis driven by cellular traction fields. J Theor Biol. 2004;227:103–120. doi: 10.1016/j.jtbi.2003.10.015. [DOI] [PubMed] [Google Scholar]
  • 48.Montminy J. Sights Set on Partial Corneal Transplants. 2000 Available at: http://focus.hms.harvard.edu/2000/Sep15_2000/ophthalmology.html.
  • 49.Nagaoka T, et al. Delayed wound healing in the absence of intercellular adhesion molecule-1 or L-selectin expression. Am J Pathol. 2000;157:237–247. doi: 10.1016/S0002-9440(10)64534-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Olsen L, Sherratt JA, Maini PK. A mechanochemical model for adult dermal wound contraction and the permanence of the contracted tissue displacement profile. J Theor Biol. 1995;177:113–128. doi: 10.1006/jtbi.1995.0230. [DOI] [PubMed] [Google Scholar]
  • 51.James PE, Jackson SK, Grinbergy OY, Swartz HM. The effects of endotoxin on oxygen consumption of various cell types in vitro: An EPR oximetry study. Free Radical Biol Med. 1995;18:641–647. doi: 10.1016/0891-5849(94)00179-n. [DOI] [PubMed] [Google Scholar]
  • 52.Gaffney EA, Pugh K, Maini PK, Arnold F. Investigating a simple model of cutaneous wound healing angiogenesis. J Math Biol. 2002;45:337–374. doi: 10.1007/s002850200161. [DOI] [PubMed] [Google Scholar]
  • 53.Blankson J, Persaud D, Siliciano RF. Latent reservoirs for HIV-1. Curr Opin Infect Dis. 1999;12:5–11. doi: 10.1097/00001432-199902000-00002. [DOI] [PubMed] [Google Scholar]
  • 54.Enholm B, et al. Comparision of VEGF, VEGF-B, VEGF-C and Ang-1mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene. 1997;14:2475–2483. doi: 10.1038/sj.onc.1201090. [DOI] [PubMed] [Google Scholar]
  • 55.Ristimäki A, Narko K, Enholm B, Joukov V, Alitalo K. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem. 1998;271:8413–8418. doi: 10.1074/jbc.273.14.8413. [DOI] [PubMed] [Google Scholar]
  • 56.Minchenko A, Salceda S, Bauer T, Caro J. Hypoxia regulatory elements of the human vascular endothelial growth factor gene. Cell Mol Biol Res. 1994;40:35–39. [PubMed] [Google Scholar]
  • 57.Sheikh AY, et al. Effect of hyperoxia on vascular endothelial growth factor levels in a wound model. Arch Surg. 2000;153:1293–1297. doi: 10.1001/archsurg.135.11.1293. [DOI] [PubMed] [Google Scholar]
  • 58.Sherratt JA, Murray JD. Models of epidermal wound healing. Proc R Soc London Ser B. 1990;241:29–36. doi: 10.1098/rspb.1990.0061. [DOI] [PubMed] [Google Scholar]
  • 59.Stokes CL, Lauffenburger DA, Williams SK. Migration of individual microvessel endothelial cells: Stochastic model and parameter measurement. J Cell Sci. 1991;99:419–430. doi: 10.1242/jcs.99.2.419. [DOI] [PubMed] [Google Scholar]
  • 60.Owen MR, Byrne HM, Lewis CE. Mathematical modelling of the use of macrophages as vehicles for drug delivery to hypoxic tumour sites. J Theor Biol. 2004;226:377–391. doi: 10.1016/j.jtbi.2003.09.004. [DOI] [PubMed] [Google Scholar]
  • 61.Stokes CL, Lauffenburger DA. Analysis of the roles of microvessel endothelial cell random motility and chemotaxis in angiogenesis. J Theor Biol. 1991;152:377–403. doi: 10.1016/s0022-5193(05)80201-2. [DOI] [PubMed] [Google Scholar]
  • 62.Chaplain MA. Avascular growth, angiogenesis and vascular growth in solid tumors: The mathematical modelling of the stages of tumor development. Math Comput Model. 1996;23:47–87. [Google Scholar]
  • 63.Baldwin ME, et al. The specificity of receptor binding by vascular endothelial growth factor-d is different in mouse and man. J Biol Chem. 2001;276:19166–19171. doi: 10.1074/jbc.M100097200. [DOI] [PubMed] [Google Scholar]
  • 64.Mäkinen T, et al. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J. 2001;20:4762–4773. doi: 10.1093/emboj/20.17.4762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Morgan CJ, Pledger WJ. In: Wound Healing: Biochemical and Clinical Aspects. Cohen IK, Diegelmann RF, Lindblad WJ, editors. Philadelphia: Saunders; 1992. pp. 63–76. [Google Scholar]
  • 66.Balasubramaniam V, Mervis CF, Maxey AM, Markham NE, Abman SH. Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: Implications for the pathogenesis of bronchopulmonary dysplasia. Am J Physiol. 2007;292:L1073–L1084. doi: 10.1152/ajplung.00347.2006. [DOI] [PubMed] [Google Scholar]
  • 67.Rakusan K, et al. ANG II type 1 receptor antagonist irbesartan inhibits coronary angiogenesis stimulated by chronic intermittent hypoxia in neonatal rats. Am J Physiol. 2007;292:H1237–H1244. doi: 10.1152/ajpheart.00965.2006. [DOI] [PubMed] [Google Scholar]
  • 68.Skeel RD, Berzins M. SIAM J Sci Stat Comp. 1990;11:1–32. [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES